Here's the live share price of Brawn Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Brawn Biotech has declined 1.59% CAGR. Over the past year, the corresponding return has been -10.92%.
Brawn Biotech’s current P/E of -10.72x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Brawn Biotech | 2.79 | 1.61 | 13.33 | 32.02 | -9.69 | 3.73 | -1.59 |
| Sun Pharmaceutical Industries | -0.45 | -1.93 | 6.73 | 4.01 | -5.65 | 20.27 | 24.12 |
| Divi's Laboratories | 1.76 | 1.22 | 10.08 | -1.39 | 10.42 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.91 | 2.3 | 8.46 | 18.77 | 12.13 | 34.66 | 22.45 |
| Cipla | -0.23 | -0.76 | -0.94 | -0.95 | 0.43 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.91 | 2.59 | -0.54 | -5.44 | -6.43 | 14.28 | 4.03 |
| Lupin | -0.58 | 3.03 | 7.37 | 8.83 | -3.47 | 41.56 | 16.62 |
| Zydus Lifesciences | 0.39 | -1.08 | -9.96 | -5.9 | -4.39 | 29.7 | 13.38 |
| Mankind Pharma | 2.59 | -1.99 | -12.76 | -4.78 | -24.54 | 15.58 | 9.07 |
| Aurobindo Pharma | 0.01 | 0.21 | 10.32 | 8.03 | -3.66 | 40.4 | 5.89 |
| Alkem Laboratories | 0.89 | -2.31 | 1.15 | 14.75 | 3 | 21.81 | 13.77 |
| Abbott India | 2.66 | -5.48 | -5.29 | -9.71 | -0.06 | 9.56 | 12.7 |
| Laurus Labs | 6.93 | 10.78 | 21.16 | 62.08 | 90.17 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.03 | 7.05 | -0.83 | 17.38 | 30.71 | 67.86 | 32.33 |
| Biocon | 1.5 | 1.25 | 11.86 | 13.21 | 14.89 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -2.83 | -0.32 | -9.25 | -23.99 | 10.63 | 23.09 | 10.09 |
| Anthem Biosciences | -0.21 | 5.28 | -16.99 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 0.14 | 0.47 | 4.61 | 4.03 | -11.37 | 18.53 | 5.49 |
| Ajanta Pharma | 4.66 | 8.5 | 9.54 | 5.34 | -2.62 | 32 | 19.59 |
| J B Chemicals & Pharmaceuticals | 1.36 | 2.28 | 8.39 | 0.84 | 0.12 | 23.13 | 28.52 |
Over the last one year, Brawn Biotech has declined 9.69% compared to peers like Sun Pharmaceutical Industries (-5.65%), Divi's Laboratories (10.42%), Torrent Pharmaceuticals (12.13%). From a 5 year perspective, Brawn Biotech has underperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 21.04 | 21.52 |
| 10 | 20.46 | 21.11 |
| 20 | 20.76 | 20.94 |
| 50 | 21.02 | 20.85 |
| 100 | 20.45 | 20.43 |
| 200 | 19.15 | 20.01 |
In the latest quarter, Brawn Biotech remained same as its previous close in promoter holding, while DII stake unchanged at 0.35%, FII holding unchanged at 0.00%, and public shareholding moved down to 45.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Dec 22, 2025, 11:48 PM IST | Brawn Biotech - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Nov 25, 2025, 9:00 PM IST | Brawn Biotech - Announcement under Regulation 30 (LODR)-Cessation |
| Nov 17, 2025, 11:44 PM IST | Brawn Biotech - Non Applicability For Filing Of Related Party Disclosure |
| Nov 14, 2025, 11:21 PM IST | Brawn Biotech - Results For The Quarter/Half Year Ended 30/09/2025 |
| Nov 14, 2025, 11:08 PM IST | Brawn Biotech - Board Meeting Outcome for Outcome Of Board Meeting |
Brawn Biotech Ltd. is a Public Limited Listed company incorporated on 07/11/1985 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1985PLC022468 and registration number is 022468. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 13.46 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brawn Biotech is ₹22.10 as on Dec 23, 2025.
The Brawn Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Brawn Biotech is ₹6.63 Cr as on Dec 23, 2025.
Today’s highest and lowest price of Brawn Biotech are ₹22.10 and ₹22.10.
The 52-week high/low is the highest and lowest price at which Brawn Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Brawn Biotech is ₹26.05 and 52-week low of Brawn Biotech is ₹15.46 as on Dec 23, 2025.
The Brawn Biotech has shown returns of 0.0% over the past day, 6.25% for the past month, 10.22% over 3 months, -10.92% over 1 year, 3.73% across 3 years, and -1.59% over 5 years.
P/E ratio of and PB ratio of Brawn Biotech are -10.72 and 1.79 on Dec 23, 2025. While the company gives a dividend yield of 0.00 per annum.